Our analysis of the contribution of Dsg3 to cancer development in these two settings suggest that, unlike E-cadherin, Dsg3 loss is not sufficient to promote carcinogenesis and that Dsg3 does not display clear tumor suppressor activity. Here, DSG3 is linked to cancer.